| AGE | Methylated | Unmethylated | Total | P value |
| AGE ≤ 50 | 17 (89.5) | 2 | 19 |
|
| AGE > 50 | 59 (88.5) | 2 | 61 |
|
| STAGE |
|
|
| p > 0.05 |
| STAGEII | 28 (%37) | 2 | 30 |
|
| STAGEIII | 42 (%55) | 2 | 44 |
|
| STAGEIV | 6 (%8) |
0 |
6 |
|
| LYMPH NODE |
|
|
|
|
| + | 65 (%85.5) | 3 | 68 | P < 0.05 |
| - | 11 (%14.5) | 1 | 12 |
|
| ER |
|
|
|
|
| + | 51 (%67.1) | 3 | 54 | P < 0.05 |
| - | 25 (%32.9) |
1 |
26 |
|
| PR |
|
|
| Nonevaluated |
| + | 39 (%51) | 3 | 42 |
|
| - | 37 (%49) | 1 | 38 |
|
| HER2/neu |
|
|
|
|
| + | 29 (%38.2) | 1 | 30 |
|
| - | 47 (%61.8) | 3 | 50 | P < 0.05 |